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Efforts to contain the spread of SARS-CoV-2 have spurred the need for reliable, rapid, and
cost-effective diagnostic methods which can be applied to large numbers of people. However,
current standard protocols for the detection of viral nucleic acids while sensitive, require a
high level of automation and sophisticated laboratory equipment to achieve throughputs that
allow whole communities to be tested on a regular basis. Here we present Cap-iLAMP
(capture and improved loop-mediated isothermal amplification) which combines a hybridi-
zation capture-based RNA extraction of gargle lavage samples with an improved colorimetric
RT-LAMP assay and smartphone-based color scoring. Cap-iLAMP is compatible with point-
of-care testing and enables the detection of SARS-CoV-2 positive samples in less than one
hour. In contrast to direct addition of the sample to improved LAMP (iLAMP), Cap-iLAMP
prevents false positives and allows single positive samples to be detected in pools of 25
negative samples, reducing the reagent cost per test to ~1 Euro per individual.
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The recent global outbreak of coronavirus disease 2019(COVID-19) has led governments to take drastic measuresto contain the spread of the severe acute respiratory syn-
drome coronavirus 2 (SARS-CoV-2). Lock-down measures and
restrictions on travel, public gatherings, and the closing of insti-
tutions such as schools, kindergartens, and universities are usually
implemented broadly, affecting the lives of infected and unin-
fected people alike. Reliable and economical mass testing
approaches for decentralized point-of-care identification of
infected individuals could greatly help to achieve more directed
and efficient containment of SARS-CoV-2.
Reverse transcription followed by quantitative PCR (RT-qPCR)
is the most widely used method to detect RNA viruses such as
SARS-CoV-2. However, its need for expensive bulky instru-
mentation and shortages of resources for RNA purification has
spurred the search for viable alternatives even though sensitive
RNA-extraction-free SARS-CoV-2 RT-qPCR-based tests are now
established1. Loop-mediated isothermal amplification (LAMP)
can rapidly amplify target nucleic acid sequences under iso-
thermal conditions2, and has been applied for molecular diag-
nostics3. The reaction requires four to six primers and produces
concatemers of double-stranded amplification products. These
can be detected directly, using intercalating dyes (e.g., SYBR
green, SYTO-dyes), by triphenylmethane dye precursors and acid
hydrolysis4,5, or by cleavage with CRISPR enzymes coupled with
lateral flow color detection of the cleavage product6. However,
these methods require an opening of the tube after the reaction,
thus posing the threat of cross-contaminating future reactions
with the amplified product. Amplification can also be detected
indirectly by hydroxynaptholblue or phenol red-based detection
of the release of protons and/or pyrophosphate generated during
DNA synthesis7. Recently, a number of studies explored ways to
detect SARS-CoV-2 RNA using RT-LAMP8–10 but they required
time-consuming RNA isolation steps before the reaction. There
have also been attempts to add sample directly into the reaction
without prior purification. However, the pH of nasopharyngeal
swab samples often varies and can adversely affect readouts11,12.
In this work, we describe a method to detect SARS-CoV-2 RNA
of a single-infected individual within a bulk sample composed of up
to 26 individual patient samples by combining a hybridization
capture-based RNA-extraction approach with smartphone app-
assisted colorimetric detection of RT-LAMP products, a procedure
that can be performed in <1 h (Fig. 1A).
We compare this method to standard extraction RT-qPCR
protocols and validate its performance on 555 gargle lavage
samples from a hospital, a nursing home previously affected by
COVID-19, and round-robin samples from a reference institution
of the German Medical Association. Compared to other point-of-
care tests, we find the herein described method to be similarly
specific and more sensitive.
Results
Development of Cap-iLAMP. We evaluated three published
RT-LAMP primer combinations targeting either the Orf1a gene
or the N gene of the SARS-CoV-2 genome9,10 using a dilution
series of synthetic viral RNA (Twist Biosciences, San Francisco,
CA, USA) and chose the two most sensitive primer sets (CV1-6
and CV15-20, Supplementary Table 1) to detect the Orf1a gene
and the N gene, respectively, for further testing (Fig. 1B and
Supplementary Fig. 1). Both primer sets could detect 500 syn-
thetic viral RNA copies after 25–30 min incubation at 65 °C as
measured by fluorescence real-time RT-LAMP (Supplementary
Fig. 1A, C). Combining the primers for the Orf1a gene
and the N gene in one reaction did not increase sensitivity
(Supplementary Fig. 1D).
Amplification in LAMP reactions is often detected color-
imetrically by a pH-sensitive dye that changes color when
extensive DNA synthesis lowers the pH of the reaction7. As noted
in a previous study11, biological samples such as nasopharyngeal
swab eluates may change the pH when added to the LAMP
reaction directly, leading to false-positive results. We found that
nasopharyngeal swab eluates tend to be more acidic than gargle
lavage samples based on the pH-dye color change in the LAMP
mix and that adding gargle lavage directly to a LAMP reaction at
a final concentration of 5% leads to false-positive results in 4.7%
of cases even before the isothermal incubation (Supplementary
Fig. 2A, B).
It would therefore be preferable to detect the amplification
product directly rather than indirectly by a pH change. To
achieve this, we deposited a drop of 0.5 microliters of a 10,000×
concentrated solution of the dye SYBR Green I to the cap of the
tube before the reaction is initiated. A similar closed tube
approach has been described for the detection of yam mosaic
virus13. Shaking the tube after the isothermal amplification
mixes the SYBR Green I with the LAMP components, stops the
reaction, and allows visual detection of SARS-CoV-2 via a color
change from orange/red to intense yellow (Fig. 1C). The color
of the reaction can be quantified as a single numerical hue
value, that is insensitive to light intensity changes and can be
derived from the red, green, blue (RGB) color model14,15, by
using freely available “camera color picker” smartphone apps.
We used the “Palette Cam” app (Alexander Mathers, App
Store) for extracting RGB values before conversion to hue. We
tested the influence of two smartphone models (Redmi 7 and
iPhone 5), as well as two different light sources (daylight and
fluorescent tube light) on the obtained hue value. While both
smartphones result in comparable hue values, daylight resulted
in a clearer separation between negative and positive samples,
than fluorescent tube light (Supplementary Fig. 3A, B). We thus
acquired all images using daylight. An additional advantage is
that detection using SYBR Green I allows us to include
acidifying enhancing enzymes in the LAMP reaction, namely
Tte UvrD helicase, which prevents unspecific late amplification
of artefacts resulting from primer interactions (Supplementary
Fig. 4A, B) and thermostable inorganic pyrophosphatase which
increases reaction speed4.
However, the addition of patient gargle lavage directly to the
improved LAMP (iLAMP) reaction resulted in false positives
(13.5 %) (Supplementary Fig. 5A). Presumably, this unspecific
amplification is due to DNA from the oral microbiome, food, or
host cells as it can be prevented by prior λ exonuclease
treatment that preferentially digests 5′-phosphorylated DNA
leaving non-phosphorylated primers and iLAMP product intact
(Supplementary Fig. 5B). Furthermore, gargle lavages from
seven infected patient samples yielded false-negative results. We,
therefore, employed a Quick extract (Lucigen, Middleton, WI,
USA) lysis16 to release more viral RNA from the capsid. But this
still resulted in one false negative out of the seven gargle lavages
from infected patients and the single SARS-CoV-2-negative
sample was falsely positive (Supplementary Fig. 5B). We,
therefore, employed a rapid (15 min) bead-capture enrichment
purification akin to mRNA isolation, using two oligonucleotides
flanking the RT-LAMP target sites (Fig. 1B and Supplementary
Table 1) immobilized on paramagnetic beads. This step reduces
non-target nucleic acids and other unwanted components in the
biological samples and also concentrates the viral RNA.
Comparing the Ct-values of RT-qPCR targeting the E gene17
after silica-based RNA-extraction with hybridization capture
targeting the E gene for the same volume of gargle lavage
suggests a capture efficiency of roughly 5% (Fig. 1D). To allow
comparison to RT-qPCR we captured viral RNA with a
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biotinylated probe for the E gene and not for the Orf1a and N
gene as used for RT-iLAMP. When RNA is concentrated from
500 µl gargle lavage to 25 µl final volume and 10 µl input volume
is used in iLAMP, this results in a detection limit of 5–25 viral
genome copies per µl of the sample before capture as the final
Cap-iLAMP formulation detects 100–500 viral copies per
reaction (Supplementary Fig. 6A, B).
The reagents required for the iLAMP reaction can be pre-
mixed and freeze-thawed at least twice. Cap-iLAMP could be
performed at point-of-care as only pipettes, a thermoblock, a
magnetic rack, and a smartphone are needed (Fig. 1E). The price
of two replicates experiments for a single test including capture
and assays for the Orf1a and N gene, as well as a positive control
and negative control, is ~30 € (Supplementary Table 2). Thus
the reagent cost for testing a single individual in a pool of 26
individual gargle lavage samples is around 1€.
Detection of SARS-CoV-2 in gargle lavage samples. To validate
the method on real samples, we used gargle lavage from hospital
patients and nursing home inhabitants and employees. All sam-
ples had previously been tested by an RT-qPCR assay targeting
the SARS-CoV-2 E gene1. Cap-iLAMP targeting the SARS-CoV-2
Orf1a gene or the N gene results in an orange/red and intense
yellow color for SARS-CoV-2 RNA negative and positive samples,
respectively (Supplementary Fig. 7A). We initially tested 12
individual gargle lavage samples employing only two wash steps
after capture. Of these samples, six had previously been tested
positive in the RT-qPCR assay (Supplementary Fig. 7B). Scoring
the color of the iLAMP reactions using a smartphone “camera
color picker” app shows that hues for SARS-CoV-2-negative and
positive samples are clearly separated, below 26° for the former
and above 37° for the latter, respectively (Supplementary Fig. 7C).
All six negative samples were identified as negative. Of the six
Fig. 1 Cap-iLAMP to detect SARS-CoV-2. A Workflow of Cap-iLAMP involves collecting and optionally pooling up to 26 gargle lavage samples, followed
by combined lysis, target RNA enrichment, and improved LAMP (iLAMP). Color hue values can be obtained using any freely available “camera color picker”
application on a smartphone. B Positions of primers and biotinylated capture oligonucleotides targeting the viral Orf1a and N gene on the SARS-CoV-2
genome. C Color change induced by mixing a drop of SYBR green I in the lid of the tube after iLAMP reaction with different input copy numbers of synthetic
viral RNA. D Capture efficiency of three samples with different viral loads was estimated relative to automated silica-based RNA extraction based on copy
number estimates for RT-qPCR assay targeting the SARS-CoV-2 E gene. Source data are provided as a Source Data file. E Equipment necessary for Cap-
iLAMP: Pipettes and pipette tips, pre-mixed reagents (including iLAMP master mix and capture bead suspension), stable buffers (lysis/binding buffer,
wash buffer, low salt buffer, elution buffer), a magnetic rack, and a thermoblock. A smartphone (not depicted) is recommended for hue color scoring.
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samples that were SARS-CoV-2-positive in the RT-qPCR assay,
four were positive in the Cap-iLAMP assay while the remaining
two were false negative. When one-twentieth of capture eluate
volume was used they were positive, suggesting that some residual
inhibition originating either from the biological sample or from
lysis/binding buffer carryover exists in these extracts. Conse-
quently, we employed three instead of two wash steps in all
subsequent experiments. Because the hue was never above 28.5°
in all subsequently tested negative samples in this study (n=
236), we consider assays with hue >28.5° as positive.
This Cap-iLAMP protocol was applied to test 30 individual
gargle lavage samples in two replicate experiments. These samples
had been previously tested positive with RT-qPCR and Ct values
ranged from 12.2 to 32.2 (Fig. 2A and Supplementary Table 3).
Nineteen of the samples had Ct values below 24 and are thus
likely to be infectious18 even if the ability of a person to infect
others may vary as viral loads fluctuate over time19 and often
from sample to sample on the same occasion. Seventeen of the
19 samples tested positive in both assays targeting the Orf1a and
the N gene, while the remaining two tested positive for one of the
genes in one of the replicate experiments. Five of the 11 samples
with Ct > 24 tested positive in assays for both genes in one of the
replicates, and 10 tested positive for one of the genes in at least
one of the replicates.
Next, we applied Cap-iLAMP to test individual gargle lavage
samples previously found to be negative with RT-qPCR (Fig. 2B).
Twenty-nine negative samples were correctly identified as
negative in both Cap-iLAMP assays targeting the Orf1a and the
N gene, while one showed amplification when targeting the Orf1a
but not the N gene. Repeating the assays for this sample resulted
in a negative assignment for both assays.
To assess the frequency of false-positive amplification under
realistic conditions a blinded experimenter analyzed a set of 192
gargle lavage samples that contained a single positive sample (Ct 22)
(Supplementary Fig. 8). The positive sample was correctly identified
with both the Orf1a and N gene assays. Additionally, one sample
Fig. 2 Detection of SARS-CoV-2 in gargle lavage samples. Data obtained from healthy individuals are shown in blue while SARS-CoV-2-positive patient
samples are depicted in green. Solid circles indicate values of the Orf1a assay while hollow circles denote values of the N gene assay. Assays with a hue
>28.5° (dotted line) are considered positive. Repeated experiments are depicted in a light color and respective samples underwent an additional freeze/
thaw cycle. A Hue of individual SARS-CoV-2-negative gargle lavage samples after Cap-iLAMP measured in duplicates. B Hue of individual SARS-CoV-2-
positive gargle lavage samples after Cap-iLAMP measured in duplicates. Ct values of individual patient gargle lavage samples obtained via RT-qPCR assay
targeting the SARS-CoV-2 E gene are stated. C Hue of gargle lavage pools after Cap-iLAMP measured in duplicates. The Ct values of spiked-in positive
samples are stated. A vertical red dotted line indicates the separation between samples with high viral loads (Ct < 24) and low viral loads (Ct≥ 24).
Samples with Ct < 24 are likely highly infectious. Source data are provided as a Source Data file.
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showed amplification in the assay targeting the N gene while
another tested positive in the assay targeting the Orf1a gene.
Suspiciously, these two samples were located in wells adjacent to the
true positive sample in the plate containing the capture eluates,
which could hint to experimental carryover. Repeating the assays
for these samples resulted in correct negative assignment for
both genes.
Next, we created 12 pools of 25 patient samples each, all of
which had been tested negative in RT-qPCR assay and in the
Cap-iLAMP assays for the Orf1a and the N gene (Fig. 2C).
To determine if components of the pooled gargle lavage still
inhibit the RT-LAMP reaction after capture, we took subsamples
of negative pools and added 1000 copies/µl of artificial viral RNA
before Cap-iLAMP. All pools were positive in both Cap-iLAMP
assays, showing that there was no substantial inhibition in these
extracts after capture.
To investigate whether it is possible to detect a single positive
individual within a pool, we added different single positive
patient samples with Ct values ranging from 12.2 to 36 to pools
of uninfected individuals so that 1/26 (3.8%) of the final volume
was composed of the infected sample (Supplementary Table 4).
Six of the 18 gargle lavage pools tested positive in both assays
targeting the Orf1a and the N gene, respectively, and nine
additional pools tested positive for the assay targeting the N
gene. The hues of the four samples were barely above the 28.5°
threshold. This demonstrates that a single SARS-CoV-2-
positive individual can be detected in a pool of 26 samples,
albeit with some loss of sensitivity compared to individual
sample testing.
Detection of SARS-CoV-2 in heat-inactivated cell-culture
supernatants. Finally, we validated Cap-iLAMP against a set of
seven reference samples of heat-inactivated cell-culture super-
natants provided by the “INSTAND” reference institution of the
German Medical Association (Duesseldorf, Germany) for round-
robin testing. These contained various amounts of SARS-CoV-2
(ring 59, 61, 63, and 64), different coronaviruses (ring 60 HCoV
OC43 and ring 65 HCoV 229E), or no virus (ring 62) and had
previously been tested via RT-qPCR1 (Fig. 3A). As shown in
Fig. 3B, all four SARS-CoV-2-containing samples were correctly
and consistently identified by both the Orf1a and N gene assays
while all samples devoid of virus or containing a different cor-
onavirus were correctly classified as negative.
Diagnostic predictive power of Cap-iLAMP. As described
above, we tested gargle lavages from single individuals (n=
221) and pools of 25 healthy individuals (n= 12) from a sum
of 521 SARS-CoV-2-negative hospital patients and nursing
home inhabitants and employees, as well as round-robin
test cell-culture supernatants void of SARS-CoV-2 (n= 3).
Among those, there was no SARS-CoV-2-negative sample for
which both Cap-iLAMP assays targeting the Orf1a or the N
gene showed amplification. For three samples, one assay was
positive, but subsequent analysis of those was negative for both
assays.
We propose two approaches for diagnostic assignment
(Supplementary Table 5). A conservative approach requires both
assays targeting the Orf1a and the N gene, respectively, to be
positive in at least one of two replicates in order to assign a
sample as SARS-CoV-2-positive, resulting in a false-positive rate
of 0% (0/236, 95% binomial confidence interval 0–1.3%)
(Supplementary Table 6). The relaxed approach requires at least
one assay to be positive to assign the sample as presumptive
positive for SARS-CoV-2, resulting in a false-positive rate of 1.3%
(3/236, 95% CI: 0.3–3.7%). For samples with high viral loads
(Ct < 24), the conservative false negative rate is 9.1% (2/22, 95%
CI: 1.1–29.2%), while the relaxed false negative rate is 0% (0/22,
95% binomial CI: 0–15.4%). Considering all SARS-CoV-2-
positive samples together, the conservative false negative rate is
20% (7/35, 95% CI: 8.4–36.9%) and the relaxed false negative rate
is 2.9% (1/35, 95% CI: 0.1–14.9%). In the pools of 26 gargle lavage
samples, the conservative false negative rate is 66.7% (12/18, 95%
CI: 41–86.7%) and the relaxed false negative rate is 16.7% (3/18,
95% CI: 1.4–34.7%). For the pools that contain gargle lavage
from individuals with Ct < 24, the relaxed false negative rate is 0%
(0/7, 95% CI 0–41%).
Discussion
Cap-iLAMP overcomes problems associated with standard RT-
LAMP pH-dependent colorimetric detection which is prone to
false positives due to pH-variability in gargle lavages and off-
target amplification. Gargle lavage cause no discomfort and is
thus more suitable than pharyngeal and nasal swabs for the fre-
quent and repeated screening of apparently healthy individuals20.
They have the additional advantage that they do not expose the
person collecting samples to any risk of infection.
In contrast to RT-qPCR approaches, no complicated equip-
ment such as qPCR machines is required. Removal of inhibitors
Fig. 3 Detection of SARS-CoV-2 in cell-culture supernatants provided for assay validation. A Ct values of individual cell-culture supernatant samples
obtained via RT-qPCR assay targeting the SARS-CoV-2 E gene. B Hue of individual cell-culture supernatant samples after Cap-iLAMP measured in
duplicates. Solid circles indicate values of the Orf1a assay while hollow circles denote values of the N gene assay. Data obtained from healthy individuals are
shown in blue while SARS-CoV-2-positive patient samples are depicted in green. Assays with a hue >28.5° (dotted line) are considered positive. Source
data are provided as a Source Data file.
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and enrichment of target nucleic acids by bead capture, combined
with a double assay of two SARS-CoV-2-specific target sites
increase accuracy. As quality controls, we recommend water
negative controls and sample-specific inhibition/positive controls
containing the sample and synthetic viral RNA for each the Orf1a
and the N gene assay. A scheme for evaluating the results is
shown in Supplementary Table 5.
Due to the removal of non-target nucleic acids and the inclu-
sion of LAMP enhancing enzymes in Cap-iLAMP, we drastically
reduce false-positive results, which were reported for previous
LAMP-based detection methods21–23. The inclusion of dye in the
cap of tubes allows them to remain closed for detection after
amplification thus reducing the risk of the contamination of
reagent with amplification products. We quantified color as a
single numeric hue value using a freely available smartphone app,
which enables point-of-care detection without the ambiguity of
an individual’s perception of color. Yin et al.15 already described
the application of hue for hydroxynaptholblue scoring that,
however, requires a custom-made “smart cup” reaction tube
holder as well as an app that is not freely available. Table 1
compares key aspects of Cap-iLAMP to other published SARS-
CoV-2 detection methods6,11,12,17.
When testing individual samples we correctly identify 100 or
91% of positive samples with high viral loads (Ct < 24) with the
relaxed (at least one assay targeting the Orf1a or the N gene
positive) and the conservative assignments (both assays positive),
respectively. Among all individual positive samples, we correctly
identify 97.1% or 80%, respectively. This level of sensitivity is
obviously not sufficient for regular diagnostic use. However, Cap-
iLAMP could be useful for screening purposes to limit the spread
of the infection, especially in settings where laboratory facilities
and equipment are not available. The relaxed assignment is
preferable when false positives are more acceptable than false
negatives, e.g., when screening personnel or visitors to a nursing
home or hospital. When compared to antigen tests which are
currently used for screening in such settings, Cap-iLAMP (in its
relaxed form) has similar specificity and higher sensitivity. In a
meta-analysis of antigen tests, the average sensitivity of antigen
tests was 56.2% (95% CI 29.5–79.8) and the average specificity
99.5% (95% CI: 98.1–99.9%)24. A comparison of sensitivity and
specificity of different point-of-care tests for SARS-CoV-2 is
shown in Supplementary Table 7.
We correctly identify 100% of pools that contain one sample
with a high viral load (Ct < 24) and 83% of all positive pools with
the relaxed criteria. This opens the prospect of rapid screening of
large numbers of people for individuals who may be highly
infectious in settings such as in schools, hospitals, airports, pris-
ons, retirement homes, or border crossings, and allows daily
testing of people at risk or working in critical infrastructure.
Based on the relaxed false-positive detection rate, for every 2600
individuals (100 pools) tested, one pool would on average be
falsely assigned as positive. Subsequent testing of individuals from
positively tested pools might be assigned with the conservative
approach to exclude false-positive assignment when infection
incidence is low.
The Cap-iLAMP method can be readily applied to numerous
human respiratory pathogens, plant pathogens, animal patho-
gens, food-borne diseases, viruses, protozoan parasites, and
fungi, for which primer combinations have been developed3.
These include Marburg virus disease, Lassa fever, Crimean-
Congo hemorrhagic fever, Ebola virus disease, Middle East
respiratory syndrome coronavirus, Nipah disease, Rift Valley
fever, and Zika, that are prioritized by the WHO (as of July
2020) as they pose the greatest public health risk due to their
epidemic potential and/or whether there is no or insufficient
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for iLAMP could be lyophilized for transportation or long-term
storage, as shown previously33,34.
Methods
Sampling of gargle lavages. 10 ml of sterile water was gargled for 10 s and spit
back into a sterile scaled urine cup1. All individuals included in this study were
asked for their voluntary assistance to participate and each individual gave written
informed consent before entry into the study. The study was approved by the
Ethics Committee of the Saxonian medical chamber (EK-allg-37/10–1). All pro-
cedures utilized in this study are in agreement with the 1975 Declaration of Hel-
sinki. Analyzed anonymized gargle lavages from hospitalized COVID-19 patients
and round-robin samples (INSTAND) were kept frozen below −80 °C for
1–2 months.
In solution capture purification of SARS-CoV-2 nucleic acids. Per reaction 20 µl
Dynabeads MyOne Streptavidin C1 bead suspension (ThermoFisher Scientific,
#650.02) are pelleted using a magnetic rack and washed twice with 500 µl combined
1× lysis/binding buffer (LysBB: 100 mM Tris-HCl, pH 7.5, 500 mM LiCl, 0.5%
LiDS, 1 mM EDTA, 5 mM DTT). Washed beads are then resuspended in 100 µl 1×
LysBB before the addition of 20pmol CV2_btn and 20pmol CV16_btn (Supple-
mentary Table 1) (or 10pmol E_Sarbeco_R2_btn for the RT-qPCR assay) and
rotation for 10 min at room temperature. Beads are pelleted and the supernatant is
discarded before resuspension in 200 µl alkaline wash solution (125 mM NaOH,
0.1% (v/v) Tween-20) and 5 min incubation at room temperature. Beads are pel-
leted with a magnetic rack and supernatant is discarded. Beads are then washed
once with 200 µl 1× LysBB before resuspension in 500 µl 2× LysBB. Prepared bead
suspension can be stored at 5 °C or used directly.
To 500 µl ready-made bead suspension an equal volume of patient gargle lavage
(sample), water (negative control), or sample with 500k copies of artificial SARS-
CoV-2 RNA (Twist Biosciences, #102024) (positive and inhibition control) is
added and mixed by pipetting. Copy numbers were reported according to
specifications by the commercial provider. The reaction is incubated at 55 °C for
10 min and then placed on a magnetic rack. The supernatant is discarded and the
beads are thoroughly resuspended in 200 µl wash buffer (20 mM Tris-HCl, pH 7.5,
500 mM LiCl, 1 mM EDTA). Beads are pelleted and the supernatant is discarded,
repeat this step once for individual or inhibited samples. Wash beads once with
200 µl low salt buffer (20 mM Tris-HCl, pH 7.5, 200 mM LiCl, 1 mM EDTA) and
discard the supernatant. Beads are resuspended in 25 µl elution buffer (20 mM
Tris-HCl, pH 7.5, 1 mM EDTA) and RNA is eluted by heating to 60 °C for 2 min.
Transfer the supernatant to a fresh 0.2 ml strip tube or use directly as input for RT-
iLAMP or RT-qPCR.
RT-iLAMP. For each sample, two assays targeting either the Orf1a or N gene are
performed. Primer mixes for both assays are prepared in bulk for quick reaction
assembly (Supplementary Table 3). 20 µl of RT-iLAMP master mix containing
either the Orf1a (CV1-6) or N gene (CV15-20) primer sets and 10 µl of capture
eluate are combined to obtain a final reaction volume of 30 µl (1× WarmStart®
Colorimetric LAMP Master Mix, NEB, Ipswich, MA, USA, #M1800L), 1 mM ATP,
1 µM SYTO 9, 1× primer mix, 0.1 ng/µl Tte UvrD Helicase (NEB, #M1202S), 0.05
U/µl thermostable inorganic pyrophosphatase (NEB, #M0296L), 0.4 U/µl Protector
RNase inhibitor (Sigma Aldrich, St. Louis, MI, USA, # 03335402001) (Supple-
mentary Tables 8 and 9). For color reactions, 0.5 µl SYBR green I is applied to the
lid of the tube without getting into contact with the reaction liquid. For transport
or preparation of large numbers of reactions, it is also possible to immobilize the
dye by drying for 15 min at 70 °C in an oven. If amplification curves should be
recorded on a qPCR machine (Bio-Rad, CFX96 Real Time System), no SYBR green
I is needed. The reaction is incubated at 65 °C for 40 min. If SYBR green I was
applied to the cap of the tube, the reaction is then stopped by shaking and can be
evaluated by eye or with any “camera color-picker” app on a smartphone within a
minute. Photographs were taken using Redmi 7 model M1810F6LG (and iPhone 5
model 1429 for Supplementary Fig. 3). We used the “Palette Cam” app (Alexander
Mathers, App Store) to score red, green, and blue (RGB) values and extracted the
hue. This can be easily done using a web tool (e.g., https://www.rapidtables.com/
convert/color/rgb-to-hsv.html) or in Microsoft Excel (=ROUNDDOWN(IF(180/
PI()*ATAN2(2*R-G-B,SQRT(3)*(G-B)) < 0,180/PI()*ATAN2(2*R-G-B,SQRT(3)*
(G-B))+ 360,180/PI()*ATAN2(2*R-G-B,SQRT(3)*(G-B))),0)). Hue can also be
scored directly when using e.g., “Color Grab (color detection)” app for android or
“Aurora” app for iOS.
A step-by-step protocol is available on Protocol Exchange (DOI: 10.21203/rs.3.
pex-1344/v1)35.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
Data are available on request from the authors. The images of colorimetric assays are
available on the Dryad repository (https://datadryad.org/stash/dataset/doi:10.5061/
dryad.2rbnzs7mk). Source data are provided with this paper.
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